Will Paychex Stock Rise On Its Upcoming Earnings?
CHONGQING, CHINA - MARCH 23: In this photo illustration, the Paychex logo is displayed on a ... More smartphone screen, with the company's latest stock market performance and candlestick charts visible in the background, highlighting Paychex's real-time financial trends, stock price fluctuations, market volatility, and investment developments within the payroll services, human resources, and financial technology sectors, on March 23, 2025 in Chongqing, China. (Photo by)
Paychex (NASDAQ:PAYX) is preparing to announce its earnings at the close of June. The consensus forecast anticipates earnings of approximately $1.20 per share, an increase from $1.12 in the same quarter last year, while revenues are projected to rise by about 6.5% year-over-year to $1.38 billion. This growth is expected to be fueled by sustained strength in the company's core Management Solutions and Professional Employer Organization (PEO) services, with operating margins likely trending upward, driven by the application of technology and data analytics, along with improved cross-selling of products.
The company boasts a current market capitalization of $57 billion. Its revenue over the past twelve months was $5.4 billion, operating profitably with $2.3 billion in operating profits and net income of $1.7 billion. Nevertheless, for those seeking upside with less volatility than individual stocks, the Trefis High Quality portfolio offers an alternative, having outperformed the S&P 500 and delivered returns surpassing 91% since its inception.
See earnings reaction history of all stocks
Here are some insights regarding one-day (1D) post-earnings returns:
Additional information regarding observed 5-Day (5D) and 21-Day (21D) returns following earnings is compiled along with the statistics in the table below.
PAYX 1D, 5D, and 21D Post Earnings Return
A relatively lower-risk strategy (though not effective if the correlation is weak) involves understanding the relationship between short-term and medium-term returns after earnings, identifying the pair with the highest correlation, and making the appropriate trade. For instance, if 1D and 5D exhibit the highest correlation, a trader can position themselves as 'long' for the next 5 days if the 1D post-earnings return is positive. Below is some correlation data based on a 5-year and a 3-year (more recent) history. It is noteworthy that the correlation 1D_5D refers to the correlation between 1D post-earnings returns and subsequent 5D returns.
PAYX Correlation Between 1D, 5D, and 21D Historical Returns
Discover more about Trefis RV strategy, which has outperformed its all-cap stocks benchmark (a combination of all three: the S&P 500, S&P mid-cap, and Russell 2000), yielding strong returns for investors. Additionally, if you're seeking upside with a smoother journey than an individual stock like Paychex, consider the High Quality portfolio, which has outperformed the S&P and achieved over 91% returns since its inception.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
38 minutes ago
- Yahoo
NV5 Awarded $250 Million NOAA Contract to Advance National Shoreline Mapping and Coastal Resilience
HOLLYWOOD, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- NV5, a provider of tech-enabled engineering, certification, and consulting solutions, announced today that it has been selected by the National Oceanic and Atmospheric Administration (NOAA) for a five-year, multiple award contract valued at up to $250 million to provide shoreline mapping services in support of the National Geodetic Survey (NGS). 'Building on over a decade of experience supporting NOAA's geospatial initiatives, NV5 is uniquely positioned to meet the technical and operational demands of this contract,' said Kurt Allen, President of NV5 Geospatial. NV5's comprehensive geospatial services will support NOAA's Coastal Mapping Program to enhance the development and maintenance of nautical charts and other essential coastal applications. NV5 will collect and analyze high-precision geospatial data using ground, aerial, and satellite platforms to ensure accurate coverage of oceanic, arctic, lake, and riverine systems and support national emergency response such as hurricane recovery. 'The mandated nature of NV5's services and our proven technical expertise and operational scale differentiate NV5 in the geospatial sector and insulate us from the recent federal funding cuts,' added Ben Heraud, CEO of NV5. 'This award reinforces our leadership in national geospatial data programs and our role in delivering innovative solutions to support infrastructure, navigation, and environmental sustainability.' About NV5 NV5 Global, Inc. (NASDAQ: NVEE) is a leading provider of tech-enabled engineering, testing, inspection, and consulting solutions for the built environment. The Company specializes in engineering design, asset management, and geospatial data analytics to support infrastructure resilience and building systems performance throughout the entire asset lifecycle. NV5 operates out of more than 100 offices nationwide and abroad. For additional information, please visit the Company's website at Also visit the Company on X, LinkedIn, and Facebook. Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. The Company cautions that these statements are qualified by important factors that could cause actual results to differ materially from those reflected by the forward-looking statements contained in this news release. Such factors include: (a) changes in demand from the local and state government and private clients that we serve; (b) general economic conditions, nationally and globally, and their effect on the market for our services; (c) competitive pressures and trends in our industry and our ability to successfully compete with our competitors; (d) changes in laws, regulations, or policies; and (e) the 'Risk Factors' set forth in the Company's most recent SEC filings. All forward-looking statements are based on information available to the Company on the date hereof, and the Company assumes no obligation to update such statements, except as required by law. Investor Relations Contact NV5 Global, CochranExecutive Vice President, Strategic Growth & Investor RelationsTel: +1-954-637-8048Email: ir@ Source: NV5 Global, in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
38 minutes ago
- Yahoo
NewAmsterdam Pharma to Host R&D Day on June 11, 2025
NAARDEN, The Netherlands and MIAMI, June 05, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or 'NewAmsterdam' or the 'Company'), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease ('CVD') with elevated low-density lipoprotein cholesterol ('LDL-C'), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that it will host an R&D Day event for analysts and investors on June 11, 2025 beginning at 9:00 a.m. ET in New York City. Please join members of our management team, including: Michael Davidson, M.D., Chief Executive Officer, John Kastelein, M.D., Ph.D., FESC, Founder and Chief Scientific Officer, BJ Jones, Chief Commercial Officer, Ian Somaiya, Chief Financial Officer, and Matthew Philippe, Executive Vice President. A live webcast of the R&D event will be available and those who intend to join virtually can pre-register for the webcast through the link here. The live webcast and supporting presentation materials will be available on the Events section of the Investor Relations page of the NewAmsterdam website at at the time of the live event. An archived replay will be available on the NewAmsterdam website. Please note advanced registration is required for in-person attendance. About ObicetrapibObicetrapib is a novel, oral, low-dose CETP inhibitor that NewAmsterdam is developing to overcome the limitations of current LDL-lowering treatments. In each of the Company's Phase 2 trials, ROSE2, TULIP, ROSE, and OCEAN, as well as the Company's Phase 3 BROOKLYN, BROADWAY and TANDEM trials, evaluating obicetrapib as monotherapy or combination therapy, the Company observed statistically significant LDL-lowering combined with a side effect profile similar to that of placebo. The Company commenced the Phase 3 PREVAIL CVOT in March 2022, which is designed to assess the potential of obicetrapib to reduce occurrences of MACE. The Company completed enrollment of PREVAIL in April 2024 and randomized over 9,500 patients. Commercialization rights of obicetrapib in Europe, either as a monotherapy or as part of a fixed-dose combination with ezetimibe, have been exclusively granted to the Menarini Group, an Italy-based, leading international pharmaceutical and diagnostics company. About NewAmsterdamNewAmsterdam Pharma (Nasdaq: NAMS) is a late-stage, clinical biopharmaceutical company whose mission is to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. We seek to fill a significant unmet need for a safe, well-tolerated and convenient LDL-lowering therapy. In multiple Phase 3 trials, NewAmsterdam is investigating obicetrapib, an oral, low-dose and once-daily CETP inhibitor, alone or as a fixed-dose combination with ezetimibe, as LDL-C lowering therapies to be used as an adjunct to statin therapy for patients at risk of CVD with elevated LDL-C, for whom existing therapies are not sufficiently effective or well tolerated. Company ContactMatthew PhilippeP: Media ContactSpectrum Science on behalf of NewAmsterdamJaryd LeadyP: 1-856-803-7855jleady@ Investor ContactPrecision AQ on behalf of NewAmsterdamAustin MurtaghP:
Yahoo
38 minutes ago
- Yahoo
Redfin Reports Some Would-Be Home Sellers Are Stepping Back as Market Tilts Toward Buyers
Many prospective homebuyers are sidelined by near-record costs and economic uncertainty, creating a buyer's market in many parts of the country. That's deterring some would-be sellers. SEATTLE, June 05, 2025--(BUSINESS WIRE)--(NASDAQ: RDFN) — New listings of U.S. homes for sale rose 6.3% year over year during the four weeks ending June 1, one of the smallest increases of the last three months. That's according to a new report from Redfin ( the technology-powered real estate brokerage. New listings declined year over year in 11 of the 50 most populous U.S. metros, with the biggest drops in San Jose, CA and four Florida metros: Orlando, Fort Lauderdale, Tampa and West Palm Beach. Zooming in on recent weeks, new listings fell during the second half of May. While it's typical for listings to decline after peaking in mid-May, this year's drop was the biggest for that time period in a decade. On the buying side, pending home sales declined 0.4% year over year to their lowest May level since 2020, and mortgage-purchase applications fell 3% week over week. Prospective buyers are backing off because housing costs are near record highs, with the median home-sale price up 1.2% year over year and the weekly average mortgage rate approaching 7%, and because the U.S. economy is unpredictable. While there are hundreds of thousands more home sellers than buyers in the market—and new listings are still rising—the recent decline in listings suggests some of this spring's would-be sellers are backing off. The typical home now sells for about 1% less than its asking price, the biggest discount for this time of year since 2020, and just about 28% of homes sell for above their asking price, down from 32% at this time last year. "If a home is in a desirable neighborhood, especially if it's fixed up, it will sell fairly quickly," said Ben Ambroch, a Redfin Premier agent in Milwaukee. "But even that type of home now gets two or three offers, as opposed to the 10 offers it would have gotten a few years ago. Sellers of homes that need work in fringe neighborhoods should be able to find a buyer, but it's important they come to the table with realistic expectations on price and timing, and a willingness to negotiate. Price within a fair range based on the neighborhood, understand that buyers will be inspecting the home, and be prepared to give concessions." For Redfin economists' takes on the housing market, please visit Redfin's "From Our Economists" page. Leading indicators Indicators of homebuying demand and activity Value (if applicable) Recent change Year-over-year change Source Daily average 30-year fixed mortgage rate 6.87% (June 4) Down from 6.97% one week earlier Down from 7.17% Mortgage News Daily Weekly average 30-year fixed mortgage rate 6.89% (week ending May 29) Highest level since Feb. Down from 7.03% Freddie Mac Mortgage-purchase applications (seasonally adjusted) Down 4% from a week earlier (as of week ending May 30) Up 18% Mortgage Bankers Association Redfin Homebuyer Demand Index Down 3% from a month earlier (as of week ending June 1) Up 1% A measure of tours and other homebuying services from Redfin agents Google searches for "home for sale" Up 20% from a month earlier (as of June 1) Up 20% Google Trends ShowingTime stats have been excluded this week to ensure data accuracy. Key housing-market data U.S. highlights: Four weeks ending June 1, 2025 Redfin's national metrics include data from 400+ U.S. metro areas, and are based on homes listed and/or sold during the period. Weekly housing-market data goes back through 2015. Subject to revision. Four weeks ending June 1, 2025 Year-over-year change Notes Median sale price $393,750 1.2% Median asking price $425,975 4.9% Median monthly mortgage payment $2,863 at a 6.89% mortgage rate 4% $20 shy of record high Pending sales 88,141 -0.4% New listings 104,380 6.3% Active listings 1,132,818 14.4% Smallest increase in over a year Months of supply 4 +0.7 pts. 4 to 5 months of supply is considered balanced, with a lower number indicating seller's market conditions Share of homes off market in two weeks 38.7% Down from 42% Median days on market 36 +4 days Share of homes sold above list price 28.4% Down from 32% Average sale-to-list price ratio 99.1% Down from 99.5% Metro-level highlights: Four weeks ending June 1, 2025 Redfin's metro-level data includes the 50 most populous U.S. metros. Select metros may be excluded from time to time to ensure data accuracy. Metros with biggest year-over-year increases Metros with biggest year-over-year decreases Notes Median sale price Philadelphia (11.4%) Detroit (10.6%) Pittsburgh (7.4%) Miami (7.1%) New Brunswick, NJ (6.9%) Oakland, CA (-8.5%) Dallas (-4.5%) Jacksonville, FL (-3.6%) Houston (-2.4%) Austin, TX (-1.6%) Declined in 9 metros Pending sales Cincinnati (10.9%) Chicago (6.5%) Boston (5.7%) Montgomery County, PA (4.7%) Indianapolis (4.2%) Miami (-19.6%) San Jose, CA (-16.2%) Fort Lauderdale, FL (-15.9%) Las Vegas (-15.4%) San Diego (-12.2%) New listings Houston (13.9%) Washington, D.C. (13.5%) Montgomery County, PA (13.2%) Seattle (12%) Cincinnati (11.4%) San Jose, CA (-9%) Orlando, FL (-8.3%) Fort Lauderdale, FL (-6.8%) Tampa, FL (-6.8%) West Palm Beach, FL (-5.5%) Declined in 11 metros To view the full report, including charts, please visit: About Redfin Redfin ( is a technology-powered real estate company. We help people find a place to live with brokerage, rentals, lending, and title insurance services. We run the country's #1 real estate brokerage site. Our customers can save thousands in fees while working with a top agent. Our home-buying customers see homes first with on-demand tours, and our lending and title services help them close quickly. Our rentals business empowers millions nationwide to find apartments and houses for rent. Since launching in 2006, we've saved customers more than $1.8 billion in commissions. We serve approximately 100 markets across the U.S. and Canada and employ over 4,000 people. Redfin's subsidiaries and affiliated brands include: Bay Equity Home Loans®, Rent.™, Apartment Guide®, Title Forward® and WalkScore®. For more information or to contact a local Redfin real estate agent, visit To learn about housing market trends and download data, visit the Redfin Data Center. To be added to Redfin's press release distribution list, email press@ To view Redfin's press center, click here. View source version on Contacts Contact RedfinRedfin Journalist Services:Tana Kelleypress@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
